Excerpts from Mr. Buffett’s shareholder letters over the years
discussing share repurchases. [Updated 2017]
1980 Letter to
Shareholders
(We can’t resist pausing here for a short commercial. One
usage of retained earnings we often greet with special enthusiasm when
practiced by companies in which we have an investment interest is repurchase of
their own shares. The reasoning is simple: if a fine business is selling in the
market place for far less than intrinsic value, what more certain or more
profitable utilization of capital can there be than significant enlargement of
the interests of all owners at that bargain price? The competitive nature of
corporate acquisition activity almost guarantees the payment of a full—frequently
more than full price when a company buys the entire ownership of another
enterprise. But the auction nature of security markets often allows finely-run
companies the opportunity to purchase portions of their own businesses at a
price under 50% of that needed to acquire the same earning power through the
negotiated acquisition of another enterprise.)
1984 Letter to
Shareholders
When companies with outstanding businesses and comfortable
financial positions find their shares selling far below intrinsic value in the
marketplace, no alternative action can benefit shareholders as surely as repurchases.
(Our endorsement of repurchases is limited to those dictated
by price/value relationships and does not extend to the “greenmail”
repurchase—a practice we find odious and repugnant. In these transactions, two
parties achieve their personal ends by exploitation of an innocent and
unconsulted third party. The players are: (1) the “shareholder” extortionist
who, even before the ink on his stock certificate dries, delivers his
“your-money-or-your-life” message to managers; (2) the corporate insiders who
quickly seek peace at any price—as long as the price is paid by someone else;
and (3) the shareholders whose money is used by (2) to make (1) go away. As the
dust settles, the mugging, transient shareholder gives his speech on “free
enterprise”, the muggee management gives its speech on “the best interests of
the company”, and the innocent shareholder standing by mutely funds the
payoff.)
The companies in which we have our largest investments have
all engaged in significant stock repurchases at times when wide discrepancies
existed between price and value. As shareholders, we find this encouraging and
rewarding for two important reasons—one that is obvious, and one that is subtle
and not always understood. The obvious point involves basic arithmetic: major repurchases
at prices well below per-share intrinsic business value immediately increase,
in a highly significant way, that value. When companies purchase their own
stock, they often find it easy to get $2 of present value for $1. Corporate acquisition
programs almost never do as well and, in a discouragingly large number of
cases, fail to get anything close to $1 of value for each $1 expended.
The other benefit of repurchases is less subject to precise
measurement but can be fully as important over time. By making repurchases when
a company’s market value is well below its business value, management clearly
demonstrates that it is given to actions that enhance the wealth of
shareholders, rather than to actions that expand management’s domain but that
do nothing for (or even harm) shareholders. Seeing this, shareholders and
potential shareholders increase their estimates of future returns from the
business. This upward revision, in turn, produces market prices more in line
with intrinsic business value. These prices are entirely rational. Investors
should pay more for a business that is lodged in the hands of a manager with
demonstrated pro-shareholder leanings than for one in the hands of a self-interested
manager marching to a different drummer.
...The key word is “demonstrated”. A manager who
consistently turns his back on repurchases, when these clearly are in the
interests of owners, reveals more than he knows of his motivations. No matter how
often or how eloquently he mouths some public relations-inspired phrase such as
“maximizing shareholder wealth” (this season’s favorite), the market correctly
discounts assets lodged with him. His heart is not listening to his mouth—and,
after a while, neither will the market.
We have prospered in a very major way—as have other
shareholders—by the large share repurchases of GEICO, Washington Post, and
General Foods, our three largest holdings. (Exxon, in which we have our fourth
largest holding, has also wisely and aggressively repurchased shares but, in
this case, we have only recently established our position.) In each of these
companies, shareholders have had their interests in outstanding businesses
materially enhanced by repurchases made at bargain prices. We feel very comfortable
owning interests in businesses such as these that offer excellent economics
combined with shareholder-conscious managements.
1990 Letter to
Shareholders
When Coca-Cola uses retained earnings to repurchase its
shares, the company increases our percentage ownership in what I regard to be
the most valuable franchise in the world. (Coke also, of course, uses retained
earnings in many other value-enhancing ways.) Instead of repurchasing stock,
Coca-Cola could pay those funds to us in dividends, which we could then use to
purchase more Coke shares. That would be a less efficient scenario: Because of taxes
we would pay on dividend income, we would not be able to increase our proportionate
ownership to the degree that Coke can, acting for us. If this less efficient
procedure were followed, however, Berkshire would report far greater
“earnings.”
1994 Letter to
Shareholders
Intrinsic Value and
Capital Allocation
Understanding intrinsic value is as important for managers
as it is for investors. When managers are making capital allocation
decisions—including decisions to repurchase shares—it’s vital that they act in
ways that increase per-share intrinsic value and avoid moves that decrease it.
This principle may seem obvious but we constantly see it violated. And, when misallocations
occur, shareholders are hurt.
For example, in contemplating business mergers and
acquisitions, many managers tend to focus on whether the transaction is
immediately dilutive or anti-dilutive to earnings per share (or, at financial
institutions, to per-share book value). An emphasis of this sort carries great
dangers. Going back to our college-education example, imagine that a
25-year-old first-year MBA student is considering merging his future economic
interests with those of a 25-year-old day laborer. The MBA student, a
non-earner, would find that a “share-for-share” merger of his equity interest in
himself with that of the day laborer would enhance his near-term earnings (in a
big way!). But what could be sillier for the student than a deal of this kind?
In corporate transactions, it’s equally silly for the
would-be purchaser to focus on current earnings when the prospective acquiree
has either different prospects, different amounts of non-operating assets, or a
different capital structure. At Berkshire, we have rejected many merger and
purchase opportunities that would have boosted current and near-term earnings
but that would have reduced per-share intrinsic value. Our approach, rather,
has been to follow Wayne Gretzky’s advice: “Go to where the puck is going to
be, not to where it is.” As a result, our shareholders are now many billions of
dollars richer than they would have been if we had used the standard catechism.
The sad fact is that most major acquisitions display an
egregious imbalance: They are a bonanza for the shareholders of the acquiree;
they increase the income and status of the acquirer’s management; and they are
a honey pot for the investment bankers and other professionals on both sides.
But, alas, they usually reduce the wealth of the acquirer’s shareholders, often
to a substantial extent. That happens because the acquirer typically gives up
more intrinsic value than it receives. Do that enough, says John Medlin, the
retired head of Wachovia Corp., and “you are running a chain letter in
reverse.”
Over time, the skill with which a company’s managers
allocate capital has an enormous impact on the enterprise’s value. Almost by
definition, a really good business generates far more money (at least after its
early years) than it can use internally. The company could, of course,
distribute the money to shareholders by way of dividends or share repurchases.
But often the CEO asks a strategic planning staff, consultants or investment
bankers whether an acquisition or two might make sense. That’s like asking your
interior decorator whether you need a $50,000 rug.
The acquisition problem is often compounded by a biological
bias: Many CEO’s attain their positions in part because they possess an
abundance of animal spirits and ego. If an executive is heavily endowed with
these qualities—which, it should be acknowledged, sometimes have their
advantages—they won’t disappear when he reaches the top. When such a CEO is
encouraged by his advisors to make deals, he responds much as would a teenage
boy who is encouraged by his father to have a normal sex life. It’s not a push
he needs.
Some years back, a CEO friend of mine—in jest, it must be
said—unintentionally described the pathology of many big deals. This friend,
who ran a property-casualty insurer, was explaining to his directors why he wanted
to acquire a certain life insurance company. After droning rather
unpersuasively through the economics and strategic rationale for the
acquisition, he abruptly abandoned the script. With an impish look, he simply
said: “Aw, fellas, all the other kids have one.”
At Berkshire, our managers will continue to earn
extraordinary returns from what appear to be ordinary businesses. As a first
step, these managers will look for ways to deploy their earnings advantageously
in their businesses. What’s left, they will send to Charlie and me. We then
will try to use those funds in ways that build per-share intrinsic value. Our
goal will be to acquire either part or all of businesses that we believe we
understand, that have good, sustainable underlying economics, and that are run
by managers whom we like, admire and trust.
1999 Letter to
Shareholders
Share Repurchases
Recently, a number of shareholders have suggested to us that
Berkshire repurchase its shares. Usually the requests were rationally based,
but a few leaned on spurious logic.
There is only one combination of facts that makes it
advisable for a company to repurchase its shares: First, the company has
available funds — cash plus sensible borrowing capacity — beyond the near-term
needs of the business and, second, finds its stock selling in the market below
its intrinsic value, conservatively-calculated. To this we add a caveat:
Shareholders should have been supplied all the information they need for estimating
that value. Otherwise, insiders could take advantage of their uninformed
partners and buy out their interests at a fraction of true worth. We have, on
rare occasions, seen that happen. Usually, of course, chicanery is employed to
drive stock prices up, not down.
The business “needs” that I speak of are of two kinds:
First, expenditures that a company must make to maintain its competitive
position (e.g., the remodeling of stores at Helzberg’s) and, second, optional outlays,
aimed at business growth, that management expects will produce more than a
dollar of value for each dollar spent (R. C. Willey’s expansion into Idaho).
When available funds exceed needs of those kinds, a company
with a growth-oriented shareholder population can buy new businesses or
repurchase shares. If a company’s stock is selling well below intrinsic value,
repurchases usually make the most sense. In the mid-1970s, the wisdom of making
these was virtually screaming at managements, but few responded. In most cases,
those that did made their owners much wealthier than if alternative courses of
action had been pursued. Indeed, during the 1970s (and, spasmodically, for some
years thereafter) we searched for companies that were large repurchasers of
their shares. This often was a tipoff that the company was both undervalued and
run by a shareholder-oriented management.
That day is past. Now, repurchases are all the rage, but are
all too often made for an unstated and, in our view, ignoble reason: to pump or
support the stock price. The shareholder who chooses to sell today, of course,
is benefitted by any buyer, whatever his origin or motives. But the continuing shareholder is penalized by
repurchases above intrinsic value. Buying dollar bills for $1.10 is not good
business for those who stick around.
Charlie and I admit that we feel confident in estimating
intrinsic value for only a portion of traded equities and then only when we
employ a range of values, rather than some pseudo-precise figure. Nevertheless,
it appears to us that many companies now making repurchases are overpaying
departing shareholders at the expense of those who stay. In defense of those
companies, I would say that it is natural for CEOs to be optimistic about their
own businesses. They also know a whole lot more about them than I do. However,
I can’t help but feel that too often today’s repurchases are dictated by
management’s desire to “show confidence” or be in fashion rather than by a
desire to enhance per-share value.
Sometimes, too, companies say they are repurchasing shares
to offset the shares issued when stock options granted at much lower prices are
exercised. This “buy high, sell low” strategy is one many unfortunate investors
have employed — but never intentionally! Managements, however, seem to follow this
perverse activity very cheerfully.
Of course, both option grants and repurchases may make sense
— but if that’s the case, it’s not because the two activities are logically
related. Rationally, a company’s decision to repurchase shares or to issue them
should stand on its own feet. Just because stock has been issued to satisfy
options — or for any other reason — does not mean that stock should be
repurchased at a price above intrinsic value. Correspondingly, a stock that sells
well below intrinsic value should be repurchased whether or not stock has
previously been issued (or may be because of outstanding options).
You should be aware that, at certain times in the past, I
have erred in not making repurchases.
My appraisal of Berkshire’s value was then too conservative or I was too
enthused about some alternative use of funds. We have therefore missed some
opportunities — though Berkshire’s trading volume at these points was too light
for us to have done much buying, which means that the gain in our per-share
value would have been minimal. (A repurchase of, say, 2% of a company’s shares
at a 25% discount from per-share intrinsic value produces only a ½% gain in
that value at most — and even less if the funds could alternatively have been
deployed in value-building moves.)
Some of the letters we’ve received clearly imply that the
writer is unconcerned about intrinsic value considerations but instead wants us
to trumpet an intention to repurchase so that the stock will rise (or quit
going down). If the writer wants to sell tomorrow, his thinking makes sense —
for him! — but if he intends to hold, he should instead hope the stock falls
and trades in enough volume for us to buy a lot of it. That’s the only way a
repurchase program can have any real benefit for a continuing shareholder.
We will not repurchase shares unless we believe Berkshire
stock is selling well below intrinsic value, conservatively calculated. Nor
will we attempt to talk the stock up or down. (Neither publicly or privately have
I ever told anyone to buy or sell Berkshire shares.) Instead we will give all
shareholders — and potential shareholders — the same valuation-related
information we would wish to have if our positions were reversed.
2011 Letter to
Shareholders
Share Repurchases
Last September, we announced that Berkshire would repurchase
its shares at a price of up to 110% of book value. We were in the market for
only a few days – buying $67 million of stock – before the price advanced
beyond our limit. Nonetheless, the general importance of share repurchases
suggests I should focus for a bit on the subject.
Charlie and I favor repurchases when two conditions are met:
first, a company has ample funds to take care of the operational and liquidity
needs of its business; second, its stock is selling at a material discount to
the company’s intrinsic business value, conservatively calculated.
We have witnessed many bouts of repurchasing that failed our
second test. Sometimes, of course, infractions – even serious ones – are
innocent; many CEOs never stop believing their stock is cheap. In other instances,
a less benign conclusion seems warranted. It doesn’t suffice to say that
repurchases are being made to offset the dilution from stock issuances or
simply because a company has excess cash. Continuing shareholders are hurt unless shares are purchased below
intrinsic value. The first law of capital allocation – whether the money is
slated for acquisitions or share repurchases – is that what is smart at one
price is dumb at another.
…Charlie and I have mixed emotions when Berkshire shares
sell well below intrinsic value. We like making money for continuing
shareholders, and there is no surer way to do that than by buying an asset –
our own stock – that we know to be worth at
least x for less than that – for .9x, .8x or even lower. (As one of our directors
says, it’s like shooting fish in a barrel, after
the barrel has been drained and the fish have quit flopping.) Nevertheless, we
don’t enjoy cashing out partners at a discount, even though our doing so may
give the selling shareholders a slightly higher price than they would receive
if our bid was absent. When we are buying, therefore, we want those exiting
partners to be fully informed about the value of the assets they are selling.
At our limit price of 110% of book value, repurchases
clearly increase Berkshire’s per-share intrinsic value. And the more and the
cheaper we buy, the greater the gain for continuing shareholders. Therefore, if
given the opportunity, we will likely repurchase stock aggressively at our
price limit or lower. You should know, however, that we have no interest in
supporting the stock and that our bids will fade in particularly weak markets. Nor
will we buy shares if our cash-equivalent holdings are below $20 billion. At
Berkshire, financial strength that is unquestionable takes precedence over all
else.
Share Repurchases
In the investment world, discussions about share repurchases often become heated. But I’d suggest that participants in this debate take a deep breath: Assessing the desirability of repurchases isn’t that complicated.
From the standpoint of exiting shareholders, repurchases are always a plus. Though the day-to-day impact of these purchases is usually minuscule, it’s always better for a seller to have an additional buyer in the market.
For continuing shareholders, however, repurchases only make sense if the shares are bought at a price below intrinsic value. When that rule is followed, the remaining shares experience an immediate gain in intrinsic value. Consider a simple analogy: If there are three equal partners in a business worth $3,000 and one is bought out by the partnership for $900, each of the remaining partners realizes an immediate gain of $50. If the exiting partner is paid $1,100, however, the continuing partners each suffer a loss of $50. The same math applies with corporations and their shareholders. Ergo, the question of whether a repurchase action is value-enhancing or value-destroying for continuing shareholders is entirely purchase-price dependent.
It is puzzling, therefore, that corporate repurchase announcements almost never refer to a price above which repurchases will be eschewed. That certainly wouldn’t be the case if a management was buying an outside business. There, price would always factor into a buy-or-pass decision.
When CEOs or boards are buying a small part of their own company, though, they all too often seem oblivious to price. Would they behave similarly if they were managing a private company with just a few owners and were evaluating the wisdom of buying out one of them? Of course not.
It is important to remember that there are two occasions in which repurchases should not take place, even if the company’s shares are underpriced. One is when a business both needs all its available money to protect or expand its own operations and is also uncomfortable adding further debt. Here, the internal need for funds should take priority. This exception assumes, of course, that the business has a decent future awaiting it after the needed expenditures are made.
The second exception, less common, materializes when a business acquisition (or some other investment opportunity) offers far greater value than do the undervalued shares of the potential repurchaser. Long ago, Berkshire itself often had to choose between these alternatives. At our present size, the issue is far less likely to arise.
My suggestion: Before even discussing repurchases, a CEO and his or her Board should stand, join hands and in unison declare, “What is smart at one price is stupid at another.”
2016 Letter to
Shareholders
In the investment world, discussions about share repurchases often become heated. But I’d suggest that participants in this debate take a deep breath: Assessing the desirability of repurchases isn’t that complicated.
From the standpoint of exiting shareholders, repurchases are always a plus. Though the day-to-day impact of these purchases is usually minuscule, it’s always better for a seller to have an additional buyer in the market.
For continuing shareholders, however, repurchases only make sense if the shares are bought at a price below intrinsic value. When that rule is followed, the remaining shares experience an immediate gain in intrinsic value. Consider a simple analogy: If there are three equal partners in a business worth $3,000 and one is bought out by the partnership for $900, each of the remaining partners realizes an immediate gain of $50. If the exiting partner is paid $1,100, however, the continuing partners each suffer a loss of $50. The same math applies with corporations and their shareholders. Ergo, the question of whether a repurchase action is value-enhancing or value-destroying for continuing shareholders is entirely purchase-price dependent.
It is puzzling, therefore, that corporate repurchase announcements almost never refer to a price above which repurchases will be eschewed. That certainly wouldn’t be the case if a management was buying an outside business. There, price would always factor into a buy-or-pass decision.
When CEOs or boards are buying a small part of their own company, though, they all too often seem oblivious to price. Would they behave similarly if they were managing a private company with just a few owners and were evaluating the wisdom of buying out one of them? Of course not.
It is important to remember that there are two occasions in which repurchases should not take place, even if the company’s shares are underpriced. One is when a business both needs all its available money to protect or expand its own operations and is also uncomfortable adding further debt. Here, the internal need for funds should take priority. This exception assumes, of course, that the business has a decent future awaiting it after the needed expenditures are made.
The second exception, less common, materializes when a business acquisition (or some other investment opportunity) offers far greater value than do the undervalued shares of the potential repurchaser. Long ago, Berkshire itself often had to choose between these alternatives. At our present size, the issue is far less likely to arise.
My suggestion: Before even discussing repurchases, a CEO and his or her Board should stand, join hands and in unison declare, “What is smart at one price is stupid at another.”